v3.26.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Common Stock
Additional Paid-in Capital
Subscription Receivable
Statutory surplus reserve
Accumulated deficits
Accumulated other comprehensive income (loss)
Non- controlling interests
Total
Balance (in Shares) at Sep. 30, 2024 5,163,946              
Balance at Sep. 30, 2024   $ 77,886,898 $ (125,000) $ 3,176,556 $ (50,448,573) $ (2,326,968) $ 153,593 $ 28,316,506
Net income (loss) from continuing operation         (273,875)     (273,875)
Net income from discontinued operation         (522,926)   (5,227) (528,153)
Foreign currency translation adjustment           (1,122,640) 6,915 (1,115,725)
Balance (in Shares) at Mar. 31, 2025 5,163,946              
Balance at Mar. 31, 2025   77,886,898 (125,000) 3,176,556 (51,245,374) (3,449,608) 155,281 26,398,753
Balance (in Shares) at Sep. 30, 2025 6,612,308              
Balance at Sep. 30, 2025   79,024,091 (125,000) 3,176,556 (54,433,757) (3,144,036) 116,604 24,614,458
Stock based compensation (in Shares) 4,050,000              
Stock based compensation   7,060,500           7,060,500
Shares Issued for cash or subscription receivables   40,940,900           40,940,900
Shares Issued for cash or subscription receivables (in Shares) 50,050,000              
Disposal of subsidiaries       (3,176,556) 3,176,556 2,313,586 (122,404) 2,191,182
Net income (loss) from continuing operation         (16,951,657)     (16,951,657)
Net income from discontinued operation         (72,256)   704 (71,552)
Foreign currency translation adjustment           1,476,436 5,096 1,481,532
Balance (in Shares) at Mar. 31, 2026 60,712,308              
Balance at Mar. 31, 2026   $ 127,025,491 $ (125,000) $ 0 $ (68,281,114) $ 645,986 $ 0 $ 59,265,363